Cargando…
Post-myocardial Infarction Heart Failure: A Review on Management of Drug Therapies
After myocardial infarction (MI), patients are at a greater risk of heart failure. Post-MI patients with left ventricular systolic dysfunction have a higher risk of mortality or morbidity. Strong and compelling data from randomized trials have demonstrated that drug therapies intended for preventing...
Autor principal: | Swaroop, Gautam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264286/ https://www.ncbi.nlm.nih.gov/pubmed/35812579 http://dx.doi.org/10.7759/cureus.25745 |
Ejemplares similares
-
Prognostic Significance of Hyponatremia in ST-elevation Myocardial Infarction/Heart Failure Patients
por: Shah, Vraj, et al.
Publicado: (2019) -
Atrial Fibrillation With Decompensated Heart Failure Complicated With Non-ST Elevation Myocardial Infarction
por: Shaban, Eman E, et al.
Publicado: (2022) -
The Use of Empagliflozin Post Myocardial Infarction
por: Ravendran, Kapilraj, et al.
Publicado: (2023) -
Cardiac Rehabilitation in a Patient With Severe Heart Failure and Ventricular Septal Defect Secondary to Acute Myocardial Infarction
por: Mazzucco, Guillermo A, et al.
Publicado: (2021) -
The Significance of Sleep Disorders in Post-myocardial Infarction Depression
por: Gutlapalli, Sai Dheeraj, et al.
Publicado: (2022)